George Golumbeski Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for George Golumbeski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of George Golumbeski. George Golumbeski is Director in ENANTA PHARMACEUTICALS INC ($ENTA) and Director in Corbus Pharmaceuticals Holdings, Inc. ($CRBP) and in Sage Therapeutics, Inc. ($SAGE) and Director in Shattuck Labs, Inc. ($STTK).
Latest Insider Trading Transactions of George Golumbeski
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CRBP, ENTA, SAGE, STTK
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 06 2021 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 84.41 | 832 | 70,229 | 832 | ||
| Dec 28 2020 | STTK | Shattuck Labs, Inc ... | Golumbeski George | Director | Option Exercise | A | 53.02 | 1,286 | 68,184 | 1,286 | |
| Jul 08 2020 | CRBP | Corbus Pharmaceuti ... | Golumbeski George | Director | Option Exercise | A | 7.91 | 81,000 | 640,710 | 81,000 | |
| Jun 11 2020 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 36.47 | 10,000 | 364,700 | 10,000 | ||
| Feb 28 2020 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 51.04 | 10,000 | 510,400 | 10,000 | |
| Jan 07 2020 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 73.53 | 976 | 71,765 | 976 | ||
| Jun 06 2019 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 177.41 | 10,000 | 1,774,100 | 10,000 | ||
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 36.61 | 9,280 | 339,741 | 0 | |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 103.65 | 9,280 | 961,897 | 0 | 9.3 K to 0 (-100.00 %) |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 36.61 | 9,280 | 339,741 | 9,280 | 0 to 9.3 K |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 36.61 | 9,280 | 339,741 | 0 | |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 103.65 | 9,280 | 961,897 | 0 | 9.3 K to 0 (-100.00 %) |
| Mar 06 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 36.61 | 9,280 | 339,741 | 9,280 | 0 to 9.3 K |
| Mar 01 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 102.54 | 5,000 | 512,700 | 5,000 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 29.02 | 7,500 | 217,650 | 0 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 25.58 | 3,728 | 95,362 | 0 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | M | 25.58 | 2,272 | 58,118 | 3,728 | |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 90.07 | 11,228 | 1,011,301 | 0 | 11.2 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 29.02 | 7,500 | 217,650 | 11,228 | 3.7 K to 11.2 K (+201.18 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 25.58 | 3,728 | 95,362 | 3,728 | 0 to 3.7 K |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Sell | S | 90.03 | 2,272 | 204,552 | 0 | 2.3 K to 0 (-100.00 %) |
| Feb 13 2019 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Buy | M | 25.58 | 2,272 | 58,118 | 2,272 | 0 to 2.3 K |
| Jan 24 2019 | SAGE | Sage Therapeutics, ... | Golumbeski George | Option Exercise | A | 137.29 | 20,000 | 2,745,800 | 20,000 | ||
| Mar 05 2018 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 78.62 | 7,500 | 589,650 | 7,500 | |
| Feb 21 2017 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 29.02 | 7,500 | 217,650 | 7,500 | |
| Feb 12 2016 | ENTA | ENANTA PHARMACEUTI ... | Golumbeski George | Director | Option Exercise | A | 25.58 | 6,000 | 153,480 | 6,000 |
Page: 1